• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV
Click for more information
0.33% $15.16

CLINUVEL PHARMACEUTICALS LIMITED - Charts / Financials

Market Cap $759.5M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The... Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. The Company is engaged in managing and expanding commercial distribution of its lead drug candidate, SCENESSE, in Europe, the United States, Israel, and Australia for the treatment of a rare, genetic metabolic disorder, erythropoietic protoporphyria (EPP). The Company’s pipeline includes PRENUMBRA, NEURACTHEL, CUV9900, and Parvysmelanotide (VLRX001). PRENUMBRA is a liquid (non-solid) injectable formulation of afamelanotide designed to provide a flexible dose of afamelanotide, a synthetic analogue of natural a-melanocyte stimulating hormone. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH), for neurological, endocrinological and degenerative disorders.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 13/05/2024 (20 minute delay) ?
Day
Open $15.20   Day High $15.21   Day Low $14.90
Daily Volume 40131
Bids   Sellers
Number Price Volume   Number Price Volume
1 $15.15 150   1 $15.20 860

Directors & Senior Management

Dr. Philippe J. Wolgen Chief Executive Officer, Managing Director, Executive Director
Mr. Darren M. Keamy Chief Financial Officer, Company Secretary
Dr. Dennis J. Wright Chief Scientific Officer
Mr. Peter Vaughan Chief Financial Officer
Prof. Jeffrey V. Rosenfeld Non-Executive Chairman of the Board
Dr. Karen A. Agersborg Non-Executive Independent Director
Sir Andrew Likierman Non-Executive Independent Director
Mrs. Brenda Mary Shanahan Non-Executive Independent Director
Mrs. Susan E. Smith Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$15.16 		Change
-0.050(0.33%) 		Mkt cap ! $759.5M
Open High Low Value Volume
$15.20 $15.21 $14.90 $606.6K 40.13K

Buyers (Bids)

No. Vol. Price($)
1 150 $15.15
 

Sellers (Offers)

Price($) Vol. No.
$15.20 860 1
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
$15.14 		  Change
-0.050 ( 0.16 %)
Open High Low Volume
$15.11 $15.21 $14.95 4220
Last updated 15.59pm 13/05/2024 ?

Top Stories

Errawarra's pegmatite discovery in WA Pilbara strikes gold on ASX

Errawarra Resources Ltd has seen its share price rise by 100 percent on news of a pegmatite swarm discovery in Western Australia.
D3E joins ASX as it hunts natural gas and helium in South Africa D3E Energy will begin trading on the Australian Stock Exchange at 11 am today, having listed late last week, with shares priced at 20 cents.
Fletcher Building navigates uncertain market dynamics in FY24 Fletcher Building has flagged a softening of its Materials and Distribution divisions in Australia and New Zealand.
Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA The ASX has picked up another miner, with Sun Silver Limited the newest silver-gold explorer to list on the ASX this Wednesday 15 May 2024.
Magnum to raise US$210M to advance Saudi green pig iron plant Through NASDAQ-listed VCCL and 2x1.Digital, Magnum Mining is kicking off a US$210M capital raise for its Saudi green pig iron plant.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.